Mirexus Biotechnologies Raises $12M in Funding

Mirexus Biotechnologies, Inc., a Guelph, ON, Canada-based natural nanomaterials company, closed a $12m funding round.

The round was led by GEL Tech (Canada), Inc., a subsidiary of Barbados-based Goddard Enterprises Ltd. (Goddard), in the form of a convertible note, with participation from the GreenSky President’s Club, an Ontario-based network of high-net worth active angel investors.

Led by President and CEO, Dr. Phil Whiting, Mirexus is commercializing PhytoSpherix™, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health.
The funds will be used to finance a factory to produce PhytoSpherix™, to boost business development, particularly in the Personal Care market, and increase R&D to develop new personal care, nutraceutical, and biomedical applications.



Join the discussion